Sara Cuadrado-Castaño Email & Phone Number

Sara Cuadrado-Castaño is a Co-Founder CEO/CSO at ViroFend Therapeutics S.L. based in New York, New York, United States, North America. My research is focused on the design and development of novel Oncolytic viruses (OVs) immunotherapies for cancer. With a strong focus on future clinical applications, my work extends from state-of-the-art in vitro screening platforms, to evaluate the potential and versatility of different OVs candidates, to the in vivo pre-clinical evaluation of therapeutic strategies in a broad spectrum of cancer models.